The CMS announced the launch of an Oncology Care Model that contains goals and incentives for practitioners in cancer care.
By Tony Hagen
Advertisement
Articles by By Tony Hagen
US-based global pharmaceuticals giant Pfizer Inc. will acquire Hospira Inc., a leading maker of sterile injectable drugs and infusion technologies, in a deal valued at $17 billion including debt.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Durvalumab Plus Enfortumab Vedotin Improves Survival in Cisplatin-Ineligible MIBC
2
Adjuvant Intismeran Autogene Plus Pembrolizumab Improves RFS and DMFS in Melanoma
3
Perioperative Enfortumab Vedotin Plus Pembrolizumab Improves ctDNA Clearance in Cisplatin-Eligible MIBC
4
Atirmociclib Plus Fulvestrant Improves PFS in HR+/HER2– Advanced Breast Cancer
5